ipl-logo

Biotechnology In Pharmaceutical Industry

796 Words4 Pages

Development of biotechnology in pharmaceutical industry provides benefits for both patients and firms. On one hand patients prosper ability to achieve much safer and specific treatment due to advanced biotechnological drugs which leads to better quality of life. Innovations in pharmaceutical industry plays critical role in improving total health in society. On the other hand pharmaceutical firms benefits from entering biotechnological industry by increasing market share and profitability and decreasing threat of imitation by competitors.
With reference to above issues, this study will try to discover new information and knowledge into important subject of development of biotechnology in pharmaceutical industry in Iran. Existing studies show …show more content…

Discovery, development and prescribing drugs save people’s life or improve quality of their lives. Proper using of medicines reduces the need for surgical intervention and prevents or decreases the length of time of hospitalization and therefore manages the healthcare costs.
Pharmaceutical industry is one of the most profitable and critical industries for each country. The market of the industry includes enormous portion of population, therefore pharmaceutical industry represents a considerable economic weight and is a strong driver of local and national economy. It employs a large number of people directly and indirectly, and makes a huge contribution to the balance of trade each year.
The industry is located in the center of world class sciences and each year a substantial amount of revenues are spending on R&D in order to access to new products and advance technologies to stay competitive in the market. Although the research process is long and expensive, with low odds of success, the medicines that do eventually gain approval greatly improve patients’ lives. The research investments of the industry provide a better life for millions of patients and a strongeconomy for …show more content…

Many of large pharmaceutical companies changed their strategies and implemented new ones such as strategic alliances with small startups and other parties to access necessary resources and capabilities to achieve competitive advantage and increase their market shares.
Biotechnology is a growth factor for many countries from their governments’ point of view. This is an economic resource and a national asset for each country. Because of importance of biotechnology development in pharmaceutical industry, it is vital to determine level of development of these advances in the world and in different countries. Several studies are done to determine development of biotechnology in various countries.
A study by Fontes and Novais (1998) about development of biotechnology in Portugal shows that development of biotechnology in different countries depends on characteristics

Show More
Related
1028 Words | 5 Pages

Many believe that the FDA has financial reasons for allowing a drug to be on the market. In 2006, a study found that” in 22% of advisory board meetings, more than half the members had direct financial in the companies whose medial products they evaluated or their rivals”. The FDA’s advisory boards should not be able to vote on companies that they have financial ties to. The FDA says they do the best they can to create an unbiased board, but it is difficult to find “top medical experts with no ties” to pharmaceutical companies. Since a number of people have complained about this, Congress decided to make the FDA cut twenty-five percent of the advisory board that has financial ties with the pharmaceutical company being evaluated over the next five years.

Read More
3132 Words | 13 Pages

OFF-LABEL PROMOTION UNDER FALSE CLAIM ACT Pharmaceutical industry plays a vital role in public health. These companies develop, manufacture and market medicines. Considering public health safety, government laid down laws and their agencies established regulations to market these medicines. Companies need to justify through clinical trials that their products are beneficial to consumers. To release a product in United States, they have to file a New Drug Application (NDA) with Food and Drug Administration (FDA) and should gain approval of the product.

Read More
1399 Words | 6 Pages

Research to date, however, casts doubt on the validity of

Read More
1417 Words | 6 Pages

What if there was a way to make prescription medicine cheaper and more accessible to people who need it? Technological innovations have been decreasing the costs of once-expensive products for over a century. Factory machines have replaced blacksmiths and calculators have reduced the labor of the human mind, thus lowering the cost to produce various products ranging from the average pair of shoes to a Tesla. Likewise, scientific researchers have resorted to using computer systems that reduce the amount of time that it takes to collect and analyze data that could prove beneficial to medical research. The field of research that is known to develop and control these computer programs is called computational biology.

Read More
1631 Words | 7 Pages

Nowadays it seems like legal drugs are more expensive than illegal ones. This dilemma occurs because the pharmaceutical industry affects the economy significantly. Although the United States is a mixed market economy, there are instances where the economy seems like a free market economy. A free market economy allows companies to determine the prices of goods free from government intervention. The pharmaceutical industry, despite several regulations set by the food and drug administration, is a free market economy.

Read More
581 Words | 3 Pages

Going into more of the technological advances in industries which is the major portion of the business. In the industry of biotechnology, to be able to develop transistors, scientists had to develop semiconductors through technology. After transistors, which is the second stage of technological advances in this field, they had to eventually develop the stage of DNA recombinant techniques which is part of science. Continuing on to the “mature stage” of these industries it requires first to have the technology and the academic scientists during this time. To be able to produce all of these products from biotechnology industries, they need to be able to have increasing knowledge about the materials and measurements which is mostly the technology involved.

Read More
924 Words | 4 Pages

Therefore, future studies with representative samples would be beneficial to further ones knowledge on this

Read More
409 Words | 2 Pages

However, there is limited evidence supporting the effectiveness

Read More
1794 Words | 8 Pages

Additionally, there has been research conducted to explore the correlation

Read More
1138 Words | 5 Pages

If those pursuing regenerative medicine can use this relationship and be clear on what is involved there is at least a conceptual bridge. Pharma is already much interested in using embryonic stem cell-derived material for drug discovery [12] and toxicology studies [13] and, while not regenerative medicine, it is building bridges with regen start-ups. It is also the case that the exceptionally high cost of some therapeutic proteins will mean pharma will not be particularly surprised if the human cell therapeutic preparations are also of high cost. The pharma sector has not as yet had good experience with biotech companies in gene-based medicines and will move with caution where it appears to be involved. However, they do use gene transfection to enhance cell properties in tightly regulated

Read More
814 Words | 4 Pages

There are many sectors of biotechnology. Some of them can, under scrutiny but others are deemed as beneficial to the future of our country it has been noted animal biotechnology has benefits such as enhanced nutritional content for human consumption, a more abundant, cheaper and very full supply, and a decrease in the number of animals needed for full supply. One article documents how

Read More
720 Words | 3 Pages

Many new companies to enter the market without burden of costly tasks such as research and development, clinical trials and manufacturing of drugs. Moreover, patent expiry is one of the reasons which is offering opportunities for lower cost generic manufacturer in terms of greater market access. Additionally, the government has increased their focus on healthcare cost cutting. It is creating pressure on the authority to allow early introduction of low-cost drugs in the

Read More
1888 Words | 8 Pages

In the “Biopharm- Seltek Negotiation”, we played the role of the buyer – Biopharm, a profitable U.S.- based pharmaceutical company. In order to produce a genetically engineered antibiotic compound – Detox - a very promising pharmaceutical product, Biopharm needed a plant with special manufacturing equipment. There were two appropriate options for this decision making process: (i) Building a new plant or (ii) Buying an

Read More
1003 Words | 5 Pages

SOLVAY GROUP: INTERNATIONAL MOBILITY & MANAGING EXPATRIATES Group F2 Problem Statement: The situation is to develop an international mobility program in order to streamline processes at Solvay which aligns the company’s business goals with individual employees’ needs . External Analysis Factor (Economic, Technological, Cultural) Implications on the problem Political: • Swelling government regulations in Pharmaceutical industryIt was difficult to enter the industry(high entry barrier, not lucrative)Existing players diversifying globally Require additional HR • Movement of HR helps in easy expansion need of an effective international mobility program (take care employees needs like personal, financial, social etc.)

Read More
1267 Words | 6 Pages

This study was compared to studies that were done in Australia and Europe which proves

Read More

More about Biotechnology In Pharmaceutical Industry

Related Topics

Open Document